var data={"title":"Dimercaprol: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Dimercaprol: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6040?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=dimercaprol-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Dimercaprol: Pediatric drug information&quot;</a> and <a href=\"topic.htm?path=dimercaprol-patient-drug-information\" class=\"drug drug_patient\">see &quot;Dimercaprol: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160824\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Bal in Oil</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160839\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antidote</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160826\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> Premedication with a histamine H<sub>1</sub> antagonist (eg, diphenhydramine) is recommended.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Arsenic or gold poisoning (acute, mild):</b> Deep IM: 2.5 mg/kg every 6 hours for 2 days, then every 12 hours for 1 day, followed by once daily for 10 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Arsenic or gold poisoning (acute, severe):</b> Deep IM: 3 mg/kg every 4 hours for 2 days, then every 6 hours for 1 day, followed every 12 hours for 10 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Mercury (inorganic) poisoning (acute):</b> Deep IM: 5 mg/kg initially, followed by 2.5 mg/kg 1-2 times/day for 10 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Lead poisoning:</b> Deep IM: <b>Note:</b> For the treatment of high blood lead levels in children, the CDC recommends chelation treatment when blood lead levels are &gt;45 mcg/dL (CDC 2002; CDC 2012; Schnur 2014); however, dimercaprol is only recommended for use (in combination with edetate CALCIUM disodium) in children whose blood lead levels are &gt;70 mcg/dL or in children with lead encephalopathy (AAP 2005; Chandran 2010). In adults, available guidelines recommend chelation therapy with blood lead levels &gt;50 mcg/dL and significant symptoms; chelation therapy may also be indicated with blood lead levels &ge;100 mcg/dL and/or symptoms (Kosnett 2007).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Blood lead levels &ge;70 mcg/dL, symptomatic lead poisoning, or lead encephalopathy (in conjunction with edetate CALCIUM disodium): 4 mg/kg every 4 hours for 2-7 days; duration of therapy of at least 3 days is recommended by some experts (Chandran 2010). <b>Note:</b> Begin treatment with edetate CALCIUM disodium with the second dimercaprol dose.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160833\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=dimercaprol-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Dimercaprol: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> Premedication with a histamine H<sub>1</sub> antagonist (eg, diphenhydramine) is recommended. Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160827\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15796178\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">No adjustment provided in manufacturer&rsquo;s labeling. Use with extreme caution or discontinue if acute renal insufficiency develops during therapy. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15796179\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">Use is contraindicated in hepatic insufficiency (except in cases of postarsenical jaundice). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160810\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intramuscular: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Bal in Oil: 100 mg/mL (3 mL) [contains benzyl benzoate, peanut oil]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160796\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160813\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Administer all injections by deep IM injection.  Rotate injection sites. Maintain an alkaline urine pH to protect renal function. When used in the treatment of lead poisoning, administer in a separate site from edetate CALCIUM disodium.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160811\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antidote for gold, arsenic (except arsine), or acute mercury poisoning (except nonalkyl mercury); adjunct to edetate CALCIUM disodium in acute lead poisoning</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Note</b>: The use of dimercaprol in the management of poisoning from other heavy metals has not been validated.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160803\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not always defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cardiovascular: Chest pain, hypertension (dose-related), tachycardia (dose-related)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Central nervous system: Anxiety, burning sensation (lips, mouth, throat), headache, nervousness, paresthesia (hand)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Diaphoresis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gastrointestinal: Abdominal pain, nausea, salivation, sore throat, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Genitourinary: Burning sensation of the penis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Hematologic &amp; oncologic: Leukopenia (polymorphonuclear)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Infection: Abscess</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Local: Pain at injection site</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Neuromuscular &amp; skeletal: Weakness</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ophthalmic: Blepharospasm, conjunctivitis, lacrimation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Renal: Renal insufficiency (acute)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Respiratory: Pharyngeal edema, rhinorrhea, throat irritation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Miscellaneous: Fever (children ~30%)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160816\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hepatic insufficiency (unless due to arsenic poisoning)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160800\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Nephrotoxicity: Potentially a nephrotoxic drug; use with caution in patients with oliguria. Maintain an alkaline urine pH to protect the kidneys (prevents dimercaprol-metal complex breakdown). Discontinue or use with extreme caution if renal insufficiency develops during treatment. Hemodialysis may be used to remove the dimercaprol-metal chelate in patients with renal dysfunction</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Glucose 6-phosphate dehydrogenase deficiency: Use with caution in patients with glucose 6-phosphate dehydrogenase deficiency; may increase the risk of hemolytic anemia.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Fevers may occur in ~30% of children and may persist for the duration of therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Lead poisoning: Investigate, identify, and remove sources of lead exposure prior to treatment; do not permit patients to re-enter the contaminated environment until lead abatement has been completed.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Heavy metal poisoning: Primary care providers should consult experts in the chemotherapy of heavy metal toxicity before using chelation drug therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol;  large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse  (AAP [&quot;Inactive&quot; 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates.  See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Peanut oil: Product contains peanut oil; use with caution in patients with peanut allergy; medication for the treatment of hypersensitivity reactions should be available for immediate use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Administration: Administer all injections deep IM at different sites; <b>not</b> for IV administration.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Not indicated for the treatment of iron, cadmium, or selenium poisoning; use in these patients may result in the production of a toxic dimercaprol-metal complex.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299205\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160804\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9367&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Iron Salts: Dimercaprol may enhance the nephrotoxic effect of Iron Salts. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Minerals (with ADEK, Folate, Iron): Dimercaprol may enhance the adverse/toxic effect of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, Dimercaprol may enhance the nephrotoxic effect of Iron Salts. <i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160807\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5026033\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. There are no adequate and well-controlled studies in pregnant women.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Lead poisoning: Lead is known to cross the placenta in amounts related to maternal plasma levels.  Prenatal lead exposure may be associated with adverse events such as spontaneous abortion, preterm delivery, decreased birth weight, and impaired neurodevelopment.  Some adverse outcomes may occur with maternal blood lead levels &lt;10 mcg/dL.  In addition, pregnant women exposed to lead may have an increased risk of gestational hypertension.  Consider chelation therapy in pregnant women with confirmed blood lead levels &ge;45 mcg/dL (pregnant women with blood lead levels &ge;70 mcg/dL should be considered for chelation regardless of trimester). There are alternatives to the use of dimercaprol and consultation with experts in lead poisoning and high-risk pregnancy is recommended. Encephalopathic pregnant women should be chelated regardless of trimester (CDC, 2010).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6151604\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if dimercaprol is excreted in breast milk; however, it is not absorbed orally, which would limit the exposure to a nursing infant. When used for the treatment of lead poisoning, the amount of lead in breast milk may range from 0.6% to 3% of the maternal serum concentration. Women with confirmed blood lead levels &ge;40 mcg/dL should not initiate breast-feeding; pumping and discarding breast milk is recommended until blood lead levels are &lt;40 mcg/dL, at which point breast-feeding may resume (CDC, 2010).  Calcium supplementation may reduce the amount of lead in breast milk.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5026037\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Renal function, urine pH, infusion-related reactions</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">For lead poisoning: Blood lead levels (baseline and 7-21 days after completing chelation therapy); hemoglobin or hematocrit, iron status, free erythrocyte protoporphyrin or zinc protoporphyrin; neurodevelopmental changes </p>\n    <p style=\"text-indent:0em;margin-top:2em;\">For arsenic poisoning: Urine arsenic concentration</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160799\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Sulfhydryl group combines with ions of various heavy metals to form relatively stable, nontoxic, soluble chelates which are excreted in urine</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160815\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: IM: Rapid; Oral: Not absorbed</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: To all tissues including the brain </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic; rapid to inactive metabolites </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: 0.5-1 hour </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine and feces via bile</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6038601\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>B.A.L. (IN)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cantilena LR Jr and Klaassen CD, &ldquo;The Effect of Chelating Agents on the Excretion of Endogenous Metals,&rdquo; <i>Toxicol Appl Pharmacol</i>, 1982, 63(3):344-50.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/6285552/pubmed\" target=\"_blank\" id=\"6285552\">6285552</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevetion (CDC), <i>Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women</i>, Atlanta: CDC; 2010.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC), &ldquo;Interpreting and Managing Blood Lead Levels &lt;10 microg/dL in Children and Reducing Childhood Exposures to Lead: Recommendations of CDC's Advisory Committee on Childhood Lead Poisoning Prevention,&rdquo; <i>MMWR Recomm Rep</i>, 2007, 56(RR-8):1-16.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/17975528/pubmed\" target=\"_blank\" id=\"17975528\">17975528</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC), <i>Managing Elevated Blood Lead Levels Among Young Children: Recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention</i>, Atlanta: CDC; 2002.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC), Low level lead exposure harms children. A renewed call for primary prevention. 2012. Available at <a href=\"https://www.cdc.gov/nceh/lead/acclpp/final_document_030712.pdf\" target=\"_blank\">https://www.cdc.gov/nceh/lead/acclpp/final_document_030712.pdf</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chandran L and Cataldo R, &ldquo;Lead Poisoning: Basics and New Developments,&rdquo; <i>Pediatr Rev</i>, 2010, 31(10):399-406.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/20889734/pubmed\" target=\"_blank\" id=\"20889734\">20889734</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gardella C, &ldquo;Lead Exposure in Pregnancy: A Review of the Literature and Argument for Routine Prenatal Screening,&rdquo; <i>Obstet Gynecol Surv</i>, 2001, 56(4):231-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/11285436/pubmed\" target=\"_blank\" id=\"11285436\">11285436</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kosnett MJ, &ldquo;Chelation for Heavy Metals (Arsenic, Lead, and Mercury): Protective or Perilous?&rdquo; <i>Clin Pharmacol Ther</i>, 2010, 88(3):412-15.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/20664538/pubmed\" target=\"_blank\" id=\"20664538\">20664538</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kosnett MJ, &ldquo;Unanswered Questions in Metal Chelation,&rdquo; <i>J Toxicol Clin Toxicol</i>, 1992, 30(4):529-47.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/1331492/pubmed\" target=\"_blank\" id=\"1331492\">1331492</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kosnett MJ, Wedeen RP, Rothenberg SJ, et al, &ldquo;Recommendations for Medical Management of Adult Lead Exposure,&rdquo; <i>Environ Health Perspect</i>, 2007, 115(3):463-71.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/17431500/pubmed\" target=\"_blank\" id=\"17431500\">17431500</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &ldquo;Lead Exposure in Children: Prevention, Detection, and Management. American Academy of Pediatrics Committee on Environmental Health,&rdquo; <i>Pediatrics</i>, 2005, 116(4):1036-46.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/16199720/pubmed\" target=\"_blank\" id=\"16199720\">16199720</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"24616453\"></a>Schnur J, John RM. Childhood lead poisoning and the new Centers for Disease Control and Prevention guidelines for lead exposure. <i>J Am Assoc Nurs Practitioners</i>. 2014;26(5):238-47.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/24616453/pubmed\" target=\"_blank\" id=\"24616453\">24616453</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shannon M, &ldquo;Severe Lead Poisoning in Pregnancy,&rdquo; <i>Ambul Pediatr</i>, 2003, 3(1):37-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dimercaprol-drug-information/abstract-text/12540252/pubmed\" target=\"_blank\" id=\"12540252\">12540252</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9367 Version 82.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F160824\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F160839\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F160826\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F160833\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F160827\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F15796178\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F15796179\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F160810\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F160796\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F160813\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F160811\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F160803\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F160816\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F160800\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299205\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F160804\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F160807\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F5026033\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F6151604\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F5026037\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F160799\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F160815\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F6038601\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9367|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=dimercaprol-patient-drug-information\" class=\"drug drug_patient\">Dimercaprol: Patient drug information</a></li><li><a href=\"topic.htm?path=dimercaprol-pediatric-drug-information\" class=\"drug drug_pediatric\">Dimercaprol: Pediatric drug information</a></li></ul></div></div>","javascript":null}